142 related articles for article (PubMed ID: 1582799)
1. Retinal pigment epithelial cells in post mortem HLA typing of corneal donors.
Baumgartner I; Asenbauer TT; Kaminski SL; Grabner G; Mayr WR
Invest Ophthalmol Vis Sci; 1992 May; 33(6):1940-5. PubMed ID: 1582799
[TBL] [Abstract][Full Text] [Related]
2. [Postmortem serologic and biochemical HLA typing with cultivated retinal pigment epithelium cells].
Nölle B; Halene M; Zavazava N; Westphal E; Duncker G; Müller-Ruchholtz W
Fortschr Ophthalmol; 1991; 88(6):629-32. PubMed ID: 1794780
[TBL] [Abstract][Full Text] [Related]
3. [HLA typing of donor corneas with extended post mortem time].
Ventura AC; Böhnke M; Löliger C; Kühnl P; Winter R; Engelmann K
Ophthalmologe; 1996 Jun; 93(3):262-7. PubMed ID: 8753989
[TBL] [Abstract][Full Text] [Related]
4. Post-mortem HLA tissue typing of retinal pigment epithelial cells.
Zavazava N; Westphal E; Duncker G; Nölle B; Müller-Ruchholtz W
Scand J Immunol Suppl; 1992; 11():192-4. PubMed ID: 1514040
[TBL] [Abstract][Full Text] [Related]
5. [Post mortem HLA phenotyping of donors of eyes. Evaluation of a serological method of microlymphotoxicity on lymphocytes and PHA lymphoblasts].
Delbosc B; Urlacher A; Tongio MM; Flament J
J Fr Ophtalmol; 1990; 13(11-12):542-6. PubMed ID: 2081844
[TBL] [Abstract][Full Text] [Related]
6. Cross-matches on donor cadaver retinal pigment epithelial cells in corneal risk patients.
Zavazava N; Nölle B; Duncker G; Jenisch S; Westphal E; Eckstein V; Müller-Ruchholtz W
Graefes Arch Clin Exp Ophthalmol; 1996 Mar; 234(3):164-70. PubMed ID: 8720715
[TBL] [Abstract][Full Text] [Related]
7. Expression of MHC class I and II molecules by cadaver retinal pigment epithelium cells: optimization of post-mortem HLA typing.
Zavazava N; Halene M; Westphal E; Nölle B; Duncker G; Eckstein E; Harpprecht J; Müller-Ruchholtz W
Clin Exp Immunol; 1991 Apr; 84(1):163-6. PubMed ID: 1901778
[TBL] [Abstract][Full Text] [Related]
8. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
[TBL] [Abstract][Full Text] [Related]
9. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma.
Liversidge JM; Sewell HF; Forrester JV
Clin Exp Immunol; 1988 Sep; 73(3):489-94. PubMed ID: 3145163
[TBL] [Abstract][Full Text] [Related]
10. Regeneration of the epithelium in organ-cultured donor corneas with extended post-mortem time.
Slettedal JK; Lyberg T; Ramstad H; Beraki K; Nicolaissen B
Acta Ophthalmol Scand; 2007 Jun; 85(4):371-6. PubMed ID: 17559462
[TBL] [Abstract][Full Text] [Related]
11. [HLA typing in high risk keratoplasty].
Hirsch N; Nölle B; Zavazava N; Westphal E; Duncker G; Rochels R; Müller-Ruchholtz W
Ophthalmologe; 1993 Apr; 90(2):174-7. PubMed ID: 8490302
[TBL] [Abstract][Full Text] [Related]
12. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
13. HLA class II DNA typing using ocular tissue and its usefulness in corneal transplantation.
Munkhbat B; Hagihara M; Sato T; Tsuchida F; Shimazaki J; Tsubota K; Tsuji K
Transplant Proc; 1996 Jun; 28(3):1257-8. PubMed ID: 8658648
[No Abstract] [Full Text] [Related]
14. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
[TBL] [Abstract][Full Text] [Related]
15. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching.
Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576
[TBL] [Abstract][Full Text] [Related]
16. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
[TBL] [Abstract][Full Text] [Related]
17. High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome.
Kögler G; Enczmann J; Rocha V; Gluckman E; Wernet P
Bone Marrow Transplant; 2005 Dec; 36(12):1033-41. PubMed ID: 16247425
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
[TBL] [Abstract][Full Text] [Related]
19. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
20. Anti-donor antibodies in allogeneic cornea transplantation.
Zavazava N; Duncker G; Jenisch S; Nölle B; Westphal E; Müller-Ruchholtz W
Transplant Proc; 1995 Feb; 27(1):1410-1. PubMed ID: 7878928
[No Abstract] [Full Text] [Related]
[Next] [New Search]
